Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK)
HKD 0.74
(2.78%)
HKD 0.74
(2.78%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 957.01 Million CNY | 12.77% |
| 2022 | 848.67 Million CNY | 0.46% |
| 2021 | 844.74 Million CNY | 135.19% |
| 2020 | 359.17 Million CNY | 3890.81% |
| 2019 | 9 Million CNY | -90.53% |
| 2018 | 95 Million CNY | 0.0% |
| 2017 | - CNY | 100.0% |
| 2016 | -60.83 Million CNY | -834.7% |
| 2015 | 8.27 Million CNY | 136.57% |
| 2014 | 3.5 Million CNY | -40.48% |
| 2013 | 5.88 Million CNY | 0.0% |
| 2012 | 5.88 Million CNY | 0.0% |
| 2011 | 5.88 Million CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | -100.0% |
| 2006 | 12 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 859.22 Million CNY | 0.0% |
| 2023 FY | 957.01 Million CNY | 12.77% |
| 2023 Q4 | 957.01 Million CNY | 0.0% |
| 2023 Q2 | 1.03 Billion CNY | 0.0% |
| 2022 FY | 848.67 Million CNY | 0.46% |
| 2022 Q2 | 670.23 Million CNY | 0.0% |
| 2022 Q4 | 848.67 Million CNY | 0.0% |
| 2021 FY | 844.74 Million CNY | 135.19% |
| 2021 Q2 | 665.85 Million CNY | 0.0% |
| 2021 Q4 | 844.74 Million CNY | 0.0% |
| 2020 Q4 | 359.17 Million CNY | 0.0% |
| 2020 Q2 | 72.84 Million CNY | 0.0% |
| 2020 FY | 359.17 Million CNY | 3890.81% |
| 2019 FY | 9 Million CNY | -90.53% |
| 2019 Q2 | 19 Million CNY | 0.0% |
| 2019 Q4 | 9 Million CNY | 0.0% |
| 2018 Q4 | 95 Million CNY | 0.0% |
| 2018 Q2 | 83.14 Million CNY | 0.0% |
| 2018 FY | 95 Million CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 100.0% |
| 2017 Q2 | -59.78 Million CNY | 0.0% |
| 2016 Q2 | 8.27 Million CNY | 0.0% |
| 2016 Q4 | -60.83 Million CNY | 0.0% |
| 2016 FY | -60.83 Million CNY | -834.7% |
| 2015 Q4 | 8.27 Million CNY | 0.0% |
| 2015 Q2 | 3.5 Million CNY | 0.0% |
| 2015 FY | 8.27 Million CNY | 136.57% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q4 | 3.5 Million CNY | 0.0% |
| 2014 FY | 3.5 Million CNY | -40.48% |
| 2013 Q2 | 5.88 Million CNY | 0.0% |
| 2013 Q4 | 5.88 Million CNY | 0.0% |
| 2013 FY | 5.88 Million CNY | 0.0% |
| 2012 FY | 5.88 Million CNY | 0.0% |
| 2012 Q4 | 5.88 Million CNY | 0.0% |
| 2012 Q2 | 5.88 Million CNY | 0.0% |
| 2011 Q4 | 5.88 Million CNY | 0.0% |
| 2011 FY | 5.88 Million CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | -100.0% |
| 2006 FY | 12 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | -46065.724% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | 3.335% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | -717.096% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | -246.493% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | -1254.854% |
| Essex Bio-Technology Limited | 36.05 Million HKD | -2554.193% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | -7376.096% |
| PuraPharm Corporation Limited | 81.09 Million HKD | -1080.145% |
| SSY Group Limited | 1.94 Billion HKD | 50.861% |
| JBM (Healthcare) Limited | 43.8 Million HKD | -2084.966% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | -61.603% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 94.241% |